Additionally, MDSCs aggravated the suppressive immune TME by contacting with M2-TAMs through IL-10 and transforming growth factor (TGF)-β, which could be attenuated by downregulation of high-mobility group box-1 (HMGB1) in RCC progression (36). The gene discussed is HMGB1; the disease is renal cell carcinoma.